IDRA: How significant is it that the MOA of IMO-3100 involves the IL-17 pathway?
Sounds potentially promising. My big concern is that IDRA is pretty much a one-trick pony now with their sole focus on IMO-8400. If that P2 in 1H14 fails, that would probably be devastating. Of course, if that trial succeeds, there would seem to be upside potential from current cheap valuation.
Market Data 
Markets 
AI
